CAS: 263351-82-2; (2α,5β,7β,10β)-4,10-Diacetoxy-13-{[(2R,3S)-3-(Benzoylamino)-2-Hydroxy-3-Phenylpropanoyl]Oxy}-1,7-Dihydroxy-9-Oxo-5,20-Epoxytax-11-En-2-Yl Benzoate

该化合物是乳胶化剂帕利塔克斯的聚合制剂,目的是提高溶性,减少毒性,其特点是与聚凝膜链的结合,通过增加细胞吸收,改善向癌细胞的分娩;这一修改允许更持续地释放帕利塔克斯,这有可能提高各种肿瘤,特别是固体肿瘤的疗效;该物质展示出类似于帕利塔克斯的类似行动机制,主要是稳定微粒和抑制细胞分裂;帕利塔克斯.皮利格洛梅克斯通常通过静脉注射进行,并正在调查其在治疗几种癌症,包括乳腺癌和肺癌方面的效力;其制定旨在尽量减少通常与传统丙氧素疗法(如...

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-10973847-B2
      优先权日:2017-06-30
      标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof
      发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R
      权利人:MASSACHUSETTS INST TECHNOLOGY
      摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.

      专利号:US-2017283878-A1
      优先权日:2015-12-11
      标题:Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers
      发明人:WONG CHI-HUEY; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI; HSU TSUI-LING
      权利人:ACADEMIA SINICA
      摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta-4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for diagnostic and therapeutic uses.

      专利号:WO-2025128098-A1
      优先权日:2023-12-13
      标 题 :Solid oral dosage forms, kits, and methods of using the same
      发明人:LI YING; LANGER ROBERT; TRAVERSO CARLO
      权利人:MASSACHUSETTS INST TECHNOLOGY; BRIGHAM & WOMENS HOSPITAL INC
      摘要:Provided herein are solid oral dosage forms, methods, and kits useful, e.g, for the extension of the residence time of active pharmaceutical agents in vivo by the synthesis of a polymer in situ in a subject. In particular, the solid oral dosage forms, methods, and kits disclosed herein are particularly useful for drugs that require more than once daily administration (e.g, drugs that have short half-lives).

      专利号:US-12180228-B2
      优先权日:2019-06-05
      标题:Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
      发明人:MOVASSAGHI MOHAMMAD; OLSSON CHASE ROBERT; SCOTT TONY Z; CHEAH JAIME; PAYETTE JOSHUA NATHANIEL
      权利人:MASSACHUSETTS INST TECHNOLOGY
      摘要:The present disclosure provides, e.g., compounds, compositions, kits, methods of synthesis, and methods of use, involving epipolythiodiketopiperazines and polythiodiketopiperazines.

      专利号:ES-2402614-A1
      优先权日:2011-10-24
      标题:CONTROLLED SYNTHESIS OF POLYGLUTAMATES WITH LOW POLIDISPERSITY AND VERSATILE ARCHITECTURES

      专利号:EP-2772497-B1
      优先权日:2011-10-24
      标 题 :Controlled synthesis of polyglutamates with low polydispersity and versatile architectures

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Markovsky E, Eldar-Boock A, Ben-Shushan D, Baabur-Cohen H, Yeini E, Pisarevsky E, Many A, Aviel-Ronen S, Barshack I, Satchi-Fainaro R. Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine. J Control Release. 2017 Mar 10;249:162-172. doi: 10.1016/j.jconrel.2017.01.044. Epub 2017 Feb 1. doi: 10.1097/COC.0000000000000247. doi: 10.1001/jamadermatol.2015.2554. doi: 10.1097/COC.0000000000000156. doi: 10.7150/ijms.8340. eCollection 2014.
      6: Muggia F, Kudlowitz D. Novel taxanes. Anticancer Drugs. 2014 May;25(5):593-8. doi: 10.1097/CAD.0000000000000053. Review. Paclitaxel poliglumex, temozolomide, and radiation for newly diagnosed high-grade glioma: a Brown University Oncology Group Study. Am J Clin Oncol. 2014 Oct;37(5):444-9. doi: 10.1097/COC.0b013e31827de92b. Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancer. Am J Clin Oncol. 2014 Apr;37(2):167-71. doi: 10.1097/COC.0b013e31826e0550.
      9: Raghavan D, Boxerman J, Jeyapalan S, Rogg J. Radiation necrosis of a high-grade glioma. Med Health R I. 2012 May;95(5):159-60. doi: 10.1097/GRF.0b013e318248050d. Review. doi: 10.1158/1078-0432.CCR-11-0981. Epub 2011 Oct 5.

      合成参考文献


      参考文献:10.1007/978-3-030-40513-7_80
      摘要:Subhan MA, Torchilin VP. Biocompatible Polymeric Nanoparticles as Promising Candidates for Drug Delivery in Cancer Treatment. 2021. In: Handbook of Polymer and Ceramic Nanotechnology.
      参考文献:10.1007/978-981-15-6255-6_12
      摘要:Tripathy S, Kesharwani R, Patel DK, Das MK. Stimuli-Responsive Polymers for Cancer Nanomedicines. 2020. In: Nano Medicine and Nano Safety.
      参考文献:10.1007/978-3-030-84262-8_13
      摘要:Punagoti RA, Vasam M, Mourya R. Applications of Dendrimers in Drug Delivery Systems. 2021. In: Nanotechnology in the Life Sciences.
      参考文献:10.1186/1471-2407-8-212
      摘要:Vicari L, Musumeci T, Giannone I, Adamo L, Conticello C, De Maria R, Pignatello R, Puglisi G, Gulisano M. Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity. BMC Cancer. 2008 Jul 25;8():212.
      参考文献:10.1007/978-981-16-8990-1_3
      摘要:Jain N, Kaushik P, Pareek A, Pareek H, Sharma MK. Plant-Based Bioactive Compounds in Cancer Therapeutics. 2022. In: Prebiotics, Probiotics and Nutraceuticals.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知